sovapharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Sova |
| Description | Novel Therapies for the Treatment of Inflammatory and Neuropathic Sova Pharmaceuticals Our Company Funding Partners --> Therapeutic Areas Science Research and Development Contact Careers Novel Therapies for the Trea |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 66.96.134.10 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
sovapharma.com Valuation
|
US$1,653,788
Last updated: 2023-05-12 16:04:40
sovapharma.com has Semrush global rank of 6,400,039. sovapharma.com has an estimated worth of US$ 1,653,788, based on its estimated Ads revenue. sovapharma.com receives approximately 190,822 unique visitors each day. Its web server is located in United States, with IP address 66.96.134.10. According to SiteAdvisor, sovapharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,653,788 |
| Daily Ads Revenue | US$1,527 |
| Monthly Ads Revenue | US$45,798 |
| Yearly Ads Revenue | US$549,567 |
| Daily Unique Visitors | 12,722 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| sovapharma.com. | A | 3600 | IP: 66.96.134.10 |
| sovapharma.com. | NS | 3600 | NS Record: ns1.startlogic.com. |
| sovapharma.com. | NS | 3600 | NS Record: ns2.startlogic.com. |
| sovapharma.com. | MX | 3600 | MX Record: 0 SovaPharma-com.mail.protection.outlook.com. |
| sovapharma.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-12 16:04:40
| Sova Pharmaceuticals Our Company Funding Partners --> Therapeutic Areas Science Research and Development Contact Careers Novel Therapies for the Treatment of Inflammatory and Neuropathic Pain A significant and growing body of literature has established that hydrogen sulfide (H 2 S) is a nociceptive modulator, acting as an agonist or sensitizer at several ion channels that represent pharmaceutical targets for the treatment of inflammatory and neuropathic pain. H 2 S is produced endogenously through only a few known pathways. In the periphery, where nociceptive signals are recognized and transmitted, the enzyme cystathionine-γ-lyase (CSE) is responsible for the production of H 2 S via catabolism of sulfur-containing substrates. In pathological conditions, increased H 2 S production causes activation or sensitization of various ligand-gated (TRPs) and voltage-gated (T-Type) ion channels, leading to pain signaling. Sova is developing novel compounds that inhibit the production of H 2 |
HTTP Headers
HTTP/1.1 200 OK Date: Sun, 19 Dec 2021 13:59:37 GMT Content-Type: text/html Content-Length: 3550 Connection: keep-alive Server: Apache/2 Last-Modified: Thu, 21 Aug 2014 04:56:23 GMT Accept-Ranges: bytes Cache-Control: max-age=3600 Etag: "dde-5011c8ad43112" Expires: Sun, 19 Dec 2021 14:59:37 GMT Age: 0 |
sovapharma.com Whois Information
Domain Name: SOVAPHARMA.COM Registry Domain ID: 1603605063_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.tucows.com Registrar URL: http://www.tucows.com Updated Date: 2021-06-09T14:53:05Z Creation Date: 2010-06-24T22:03:19Z Registry Expiry Date: 2022-06-24T22:03:19Z Registrar: Tucows Domains Inc. Registrar IANA ID: 69 Registrar Abuse Contact Email: domainabuse@tucows.com Registrar Abuse Contact Phone: +1.4165350123 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.STARTLOGIC.COM Name Server: NS2.STARTLOGIC.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-23T07:27:59Z <<< |